These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6852859)

  • 1. Natural antibodies against a polysaccharide (Bo) from sugar cane mediate its complement-activating effect.
    Li XY; Nolte R; Vogt W
    Immunobiology; 1983 Mar; 164(2):110-7. PubMed ID: 6852859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
    Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
    Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and activation of hemolytic complement by IgG antibodies: cooperativity between antibodies of different hapten specificity.
    Borsos T; Circolo A
    J Immunol; 1985 Jan; 134(1):492-4. PubMed ID: 3964818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
    Russell MW; Reinholdt J; Kilian M
    Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
    Beebe DP; Schreiber RD; Cooper NR
    J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG-protein A complexes modulate thymidine incorporation into DNA of antibody and complement-stimulated cells.
    Shearer WT; Green CG; Patel P; Langone JJ
    J Immunol; 1984 May; 132(5):2279-84. PubMed ID: 6715880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG.
    Langone JJ; Boyle MD; Borsos T
    J Immunol; 1978 Jul; 121(1):327-32. PubMed ID: 353195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.
    Goldstein IM; Kaplan HB; Radin A; Frosch M
    J Immunol; 1976 Oct; 117(4):1282-7. PubMed ID: 185296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal enzyme release from polymorphonuclear leukocytes induced by immune complexes of IgM and of IgG.
    Lucisano YM; Mantovani B
    J Immunol; 1984 Apr; 132(4):2015-20. PubMed ID: 6699405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates.
    Gadd KJ; Reid KB
    Immunology; 1981 Jan; 42(1):75-82. PubMed ID: 6780451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the classical complement pathway by a polysaccharide from sugar cane.
    Li X; Vogt W
    Immunopharmacology; 1982 Oct; 5(1):31-8. PubMed ID: 6813288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
    Starkebaum G; Arend WP; Nardella FA; Gavin SE
    J Lab Clin Med; 1980 Aug; 96(2):238-51. PubMed ID: 6772719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of activated C3 to polysaccharides and immunoglobulins.
    Capel PJ; Groeneboer O; Grosveld G; Pondman KW
    J Immunol; 1978 Dec; 121(6):2566-72. PubMed ID: 722084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma.
    Pfueller SL; Weber S; Lüscher EF
    J Immunol; 1977 Feb; 118(2):514-24. PubMed ID: 557068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.